| Year |
Citation |
Score |
| 2020 |
Vora NL, Gilmore K, Brandt A, Gustafson C, Strande N, Ramkissoon L, Hardisty E, Foreman AKM, Wilhelmsen K, Owen P, Weck KE, Berg JS, Powell CM, Powell BC. An approach to integrating exome sequencing for fetal structural anomalies into clinical practice. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 31974414 DOI: 10.1038/S41436-020-0750-4 |
0.305 |
|
| 2018 |
Marchuk DS, Crooks K, Strande N, Kaiser-Rogers K, Milko LV, Brandt A, Arreola A, Tilley CR, Bizon C, Vora NL, Wilhelmsen KC, Evans JP, Berg JS. Increasing the diagnostic yield of exome sequencing by copy number variant analysis. Plos One. 13: e0209185. PMID 30557390 DOI: 10.1371/Journal.Pone.0209185 |
0.353 |
|
| 2018 |
Porter KM, Kauffman TL, Koenig BA, Lewis KL, Rehm HL, Richards CS, Strande NT, Tabor HK, Wolf SM, Yang Y, Amendola LM, Azzariti DR, Berg JS, Bergstrom K, Biesecker LG, et al. Approaches to carrier testing and results disclosure in translational genomics research: The clinical sequencing exploratory research consortium experience. Molecular Genetics & Genomic Medicine. PMID 30133189 DOI: 10.1002/Mgg3.453 |
0.314 |
|
| 2018 |
Strande NT, Brnich SE, Roman TS, Berg JS. Navigating the nuances of clinical sequence variant interpretation in Mendelian disease. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 29988079 DOI: 10.1038/S41436-018-0100-Y |
0.342 |
|
| 2017 |
Strande NT, Riggs ER, Buchanan AH, Ceyhan-Birsoy O, DiStefano M, Dwight SS, Goldstein J, Ghosh R, Seifert BA, Sneddon TP, Wright MW, Milko LV, Cherry JM, Giovanni MA, Murray MF, et al. Evaluating the Clinical Validity of Gene-Disease Associations: An Evidence-Based Framework Developed by the Clinical Genome Resource. American Journal of Human Genetics. PMID 28552198 DOI: 10.1016/J.Ajhg.2017.04.015 |
0.312 |
|
| 2017 |
Vora NL, Powell B, Brandt A, Strande N, Hardisty E, Gilmore K, Foreman AKM, Wilhelmsen K, Bizon C, Reilly J, Owen P, Powell CM, Skinner D, Rini C, Lyerly AD, et al. Prenatal exome sequencing in anomalous fetuses: new opportunities and challenges. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 28518170 DOI: 10.1038/Gim.2017.33 |
0.309 |
|
| 2016 |
Strande NT, Berg JS. Defining the Clinical Value of a Genomic Diagnosis in the Era of Next-Generation Sequencing. Annual Review of Genomics and Human Genetics. PMID 27362341 DOI: 10.1146/Annurev-Genom-083115-022348 |
0.303 |
|
| 2016 |
Amendola LM, Jarvik GP, Leo MC, McLaughlin HM, Akkari Y, Amaral MD, Berg JS, Biswas S, Bowling KM, Conlin LK, Cooper GM, Dorschner MO, Dulik MC, Ghazani AA, Ghosh R, ... ... Strande NT, et al. Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium. American Journal of Human Genetics. PMID 27181684 DOI: 10.1016/J.Ajhg.2016.03.024 |
0.315 |
|
| 2016 |
Hunter JE, Irving SA, Biesecker LG, Buchanan A, Jensen B, Lee K, Martin CL, Milko L, Muessig K, Niehaus AD, O'Daniel J, Piper MA, Ramos EM, Schully SD, Scott AF, ... ... Strande N, et al. A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 27124788 DOI: 10.1038/Gim.2016.40 |
0.313 |
|
| 2015 |
Berg JS, Foreman AK, O'Daniel JM, Booker JK, Boshe L, Carey T, Crooks KR, Jensen BC, Juengst ET, Lee K, Nelson DK, Powell BC, Powell CM, Roche MI, Skrzynia C, ... Strande NT, et al. A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 26270767 DOI: 10.1038/Gim.2015.104 |
0.313 |
|
| 2015 |
Reid DA, Keegan S, Leo-Macias A, Watanabe G, Strande NT, Chang HH, Oksuz BA, Fenyo D, Lieber MR, Ramsden DA, Rothenberg E. Organization and dynamics of the nonhomologous end-joining machinery during DNA double-strand break repair. Proceedings of the National Academy of Sciences of the United States of America. 112: E2575-84. PMID 25941401 DOI: 10.1073/Pnas.1420115112 |
0.624 |
|
| 2014 |
Strande NT, Carvajal-Garcia J, Hallett RA, Waters CA, Roberts SA, Strom C, Kuhlman B, Ramsden DA. Requirements for 5'dRP/AP lyase activity in Ku. Nucleic Acids Research. 42: 11136-43. PMID 25200085 DOI: 10.1093/Nar/Gku796 |
0.581 |
|
| 2014 |
Waters CA, Strande NT, Pryor JM, Strom CN, Mieczkowski P, Burkhalter MD, Oh S, Qaqish BF, Moore DT, Hendrickson EA, Ramsden DA. The fidelity of the ligation step determines how ends are resolved during nonhomologous end joining. Nature Communications. 5: 4286. PMID 24989324 DOI: 10.1038/Ncomms5286 |
0.615 |
|
| 2014 |
Waters CA, Strande NT, Wyatt DW, Pryor JM, Ramsden DA. Nonhomologous end joining: a good solution for bad ends. Dna Repair. 17: 39-51. PMID 24630899 DOI: 10.1016/J.Dnarep.2014.02.008 |
0.611 |
|
| 2012 |
Strande NT, Waters CA, Ramsden DA. Resolution of complex ends by Nonhomologous end joining - better to be lucky than good? Genome Integrity. 3: 10. PMID 23276302 DOI: 10.1186/2041-9414-3-10 |
0.611 |
|
| 2012 |
Strande N, Roberts SA, Oh S, Hendrickson EA, Ramsden DA. Specificity of the dRP/AP lyase of Ku promotes nonhomologous end joining (NHEJ) fidelity at damaged ends. The Journal of Biological Chemistry. 287: 13686-93. PMID 22362780 DOI: 10.1074/Jbc.M111.329730 |
0.627 |
|
| 2010 |
Roberts SA, Strande N, Burkhalter MD, Strom C, Havener JM, Hasty P, Ramsden DA. Ku is a 5'-dRP/AP lyase that excises nucleotide damage near broken ends. Nature. 464: 1214-7. PMID 20383123 DOI: 10.1038/Nature08926 |
0.645 |
|
| Show low-probability matches. |